6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

23 trials found

diseases per page:

Showing 1 to 10 of 23 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000047341	2022/07/01	31/03/2022	Randomized controlled trial of the efficacy and feasibility of a mHealth-type dance program for peop ...	Randomized controlled trial of the efficacy and feasibility of a mHealth-type dance program for peop ...	Parkinson's disease	The dance exercise group will have one online lesson per week with a coach, 60 minutes (see Appendix ...	Department of Neurology, Fukuoka university	NULL	Pending	30years-old	75years-old	Male and Female	60	Not selected	Japan
2	NCT05128175 (ClinicalTrials.gov)	October 29, 2021	27/10/2021	Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and F ...	An Open-label, Balanced, Randomized, Five-treatment, Five-period, Five-sequence, Multiple Oral Dose, ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	15	Phase 1	India
3	NCT05220072 (ClinicalTrials.gov)	August 28, 2021	18/11/2021	Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156	An Open Label, Single-dose, Single-period Study Designed to Assess the Mass BalanceRecovery, Metabol ...	Parkinson Disease	Drug: Carbon -14 BIA 28-6156	Bial R&D Investments, S.A.	NULL	Completed	30 Years	65 Years	Male	6	Phase 1	United Kingdom
4	ChiCTR2000038852	2020-10-20	2020-10-07	Study on the effect and mechanism of cognitive-cup-tapping-balance-training on fall prevention in co ...	Study on the effect and mechanism of cognitive-cup-tapping-balance-training on fall prevention in co ...	Parkinson's disease	dual task training group :cognitive-cup-tapping balancetraining;single task training group:-cup-tapp ...	Shanghai University of Sport	NULL	Recruiting	40	80	Both	dual task training group :29;single task training group:29;control group:29;	N/A	china
5	NCT04591535 (ClinicalTrials.gov)	September 28, 2020	11/9/2020	PK Study of WD-1603 in Healthy Subjects	An Open Label, Balanced, Randomised, Four-treatment, Four-period, Four-sequence, Single Oral Dose, C ...	Parkinson Disease	Drug: WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS	Hong Kong WD Pharmaceutical Co., Limited	NULL	Recruiting	18 Years	45 Years	All	8	Phase 1	India
6	NCT04553978 (ClinicalTrials.gov)	September 18, 2020	13/9/2020	A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Cond ...	An Open Label, Balanced, Randomised, 2-treatment, 2-period, 2-sequence, Single Oral Dose, Corssover ...	Parkinson Disease	Drug: WD-1603	Hong Kong WD Pharmaceutical Co., Limited	NULL	Not yet recruiting	18 Years	45 Years	All	8	Phase 1	NULL
7	ChiCTR2000035872	2020-09-01	2020-08-19	Effect of repetitive transcranial magnetic stimulation on gait and balancefunction in patients with ...	Effect of repetitive transcranial magnetic stimulation on gait and balancefunction in patients with ...	Parkinson's disease and Parkinson's syndrome	Parkinson's disease observation group:Repetitive transcranial magnetic stimulation+Visual feedback b ...	Gansu Provincial Hospital	NULL	Pending	50	85	Both	Parkinson's disease observation group:28;Parkinson's disease control group:28;Parkinson's syndrome observation group:28;Parkinson's syndrome control group:28;		China
8	NCT04513340 (ClinicalTrials.gov)	August 13, 2020	12/8/2020	WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects	AN OPEN LABEL, BALANCED, RANDOMISED, FOUR-TREATMENT, FOUR-PERIOD, FOUR-SEQUENCE, SINGLE INTRA-ORAL A ...	Parkinson Disease	Drug: WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS	Hong Kong WD Pharmaceutical Co., Limited	NULL	Recruiting	18 Years	45 Years	All	8	Phase 1	India
9	ChiCTR2000034323	2020-08-01	2020-07-02	The effect and correlation of rehabilitation training mode combined with visual feedback balancesyst ...	The effect of rehabilitation training mode combined with visual feedback balancesystem and digital t ...	Parkinson's disease	experimental group:Combined Rehabilitation Training of visual feedback balancesystem and digital tre ...	Xianhui Feng	NULL	Pending			Both	experimental group:30;control group:30;		China
10	NCT03661125 (ClinicalTrials.gov)	April 11, 2019	4/9/2018	SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis	A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC K ...	Parkinson Disease Psychosis	Drug: Saracatinib;Drug: Placebo Oral Tablet	King's College London	AstraZeneca;King's College Hospital NHS Trust	Recruiting	40 Years	N/A	All	30	Early Phase 1	United Kingdom

First Previous1 2 3Next Last